<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="foxp2-sl-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">foxp2-sl-dis</book-part-id>
      <title-group>
        <title><italic toggle="yes">FOXP2-</italic>Related Speech and Language Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Morgan</surname>
            <given-names>Angela</given-names>
          </name>
          <degrees>BSpPath (Aud Hons), PhD</degrees>
          <aff>Director of Research and Teaching, Department of Audiology and Speech Pathology<break/>University of Melbourne<break/>Director, Neuroscience of Speech<break/>Murdoch Children&#x02019;s Research Institute<break/>Victoria, Australia</aff>
          <email>amor@unimelb.edu.au</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fisher</surname>
            <given-names>Simon E</given-names>
          </name>
          <degrees>DPhil</degrees>
          <aff>Max Planck Institute for Psycholinguistics<break/>Donders Institute for Brain, Cognition and Behavior<break/>Radboud University<break/>Nijmegen, The Netherlands</aff>
          <email>simon.fisher@mpi.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scheffer</surname>
            <given-names>Ingrid</given-names>
          </name>
          <degrees>MBBS, PhD, FRACP, FAA</degrees>
          <aff>Epilepsy Research Centre<break/>Department of Medicine and Paediatrics<break/>University of Melbourne<break/>Austin Health<break/>Victoria, Australia</aff>
          <email>i.scheffer@unimelb.edu.au</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hildebrand</surname>
            <given-names>Michael</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Epilepsy Research Centre<break/>Melbourne Brain Centre<break/>Department of Medicine<break/>University of Melbourne<break/>Austin Health<break/>Victoria, Australia</aff>
          <email>michael.hildebrand@unimelb.edu.au</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>23</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>2</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="flnb-dis" document-type="chapter"><italic toggle="yes">FLNB</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="fragilex" document-type="chapter">
<italic toggle="yes">FMR1</italic>-Related Disorders</related-object>
      <abstract id="foxp2-sl-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>All <italic toggle="yes">FOXP2-</italic>related speech and language disorders, regardless of the underlying genetic alteration, have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS &#x02013; whether caused by an alteration of <italic toggle="yes">FOXP2</italic> or of an unknown cause &#x02013; have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in <italic toggle="yes">FOXP2</italic>-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments.</p>
          <p>The underlying genetic cause of <italic toggle="yes">FOXP2-</italic>related speech and language disorders is either disruption of <italic toggle="yes">FOXP2</italic> only (referred to in this <italic toggle="yes">GeneReview</italic> as <italic toggle="yes">FOXP2</italic>-only-related speech and language disorder) or large copy number variants (i.e., contiguous gene deletions), structural variants (i.e., chromosome translocation or inversion), or maternal uniparental disomy of chromosome 7 (UPD7) involving <italic toggle="yes">FOXP2</italic> (here referred to as <italic toggle="yes">FOXP2</italic>-plus speech and language disorders). The genetic alteration determines if only speech and language problems are present (<italic toggle="yes">FOXP2</italic>-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (<italic toggle="yes">FOXP2</italic>-plus speech and language disorder). In <italic toggle="yes">FOXP2-</italic>only<italic toggle="yes">-</italic>related disorders, nonverbal (performance) IQ is typically more preserved compared to verbal IQ. Fine motor skills may be impaired (e.g., buttoning clothes, tying shoelaces), yet gross motor skills are normal. Autistic features and dysmorphic findings have been reported in a few affected individuals. In <italic toggle="yes">FOXP2-</italic>plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorder are common.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of a <italic toggle="yes">FOXP2-</italic>related speech and language disorder is established in a proband by detection of one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>A large non-recurrent contiguous gene deletion that includes <italic toggle="yes">FOXP2</italic> (52% of affected individuals)</p>
            </list-item>
            <list-item>
              <p>A sequence variant within <italic toggle="yes">FOXP2</italic> (~29%)</p>
            </list-item>
            <list-item>
              <p>Maternal uniparental disomy of chromosome 7 (UPD7) that reduces <italic toggle="yes">FOXP2</italic> expression (~11%)</p>
            </list-item>
            <list-item>
              <p>A structural variant (e.g., chromosome translocation, inversion) that disrupts <italic toggle="yes">FOXP2</italic> (~8%)</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Optimally management of the speech and/or language disorder is determined by a speech pathologist based on the individual&#x02019;s findings (typically: presence and severity of CAS, dysarthria, language deficits, and literacy impairments). A clinical psychologist or neuropsychologist may provide strategies to help manage deficits in specific cognitive domains and an occupational therapist and physiotherapist can provide strategies to help with fine and gross motor deficits, respectively.</p>
          <p><italic toggle="yes">Surveillance:</italic> Follow-up evaluations with standardized tests by a speech and language pathologist.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Clarification of the genetic status of pre-symptomatic relatives at risk identifies as early as possible those who would benefit from prompt evaluation for speech and language disorders and initiation of treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Recurrence risk for sibs of proband with a <italic toggle="yes">FOXP2-</italic>related speech and language disorder depends on the genetic alteration:</p>
          <p>Non-recurrent contiguous gene deletions (80% are <italic toggle="yes">de novo</italic> and the remainder are inherited in an autosomal dominant manner)</p>
          <p><italic toggle="yes">FOXP2</italic> sequence variants (~70% are <italic toggle="yes">de novo</italic> and the remainder are inherited in an autosomal dominant manner)</p>
          <p>Maternal UPD7 (no increased risk to sibs)</p>
          <p>A structural variant (e.g., chromosome translocation, inversion. If one parent has a structural variant, the risk to sibs is increased and depends on the specific structural variant.)</p>
          <p>Prenatal testing and preimplantation genetic diagnosis are possible if the causative genetic alteration has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="foxp2-sl-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="foxp2-sl-dis.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_foxp2-sl-dis.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">FOXP2-</italic>Related Speech and Language Disorders: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p><italic toggle="yes">FOXP2</italic>-only-related disorders</p></list-item><list-item><p><italic toggle="yes">FOXP2</italic>-plus-related disorders</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="foxp2-sl-dis.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="foxp2-sl-dis.Diagnosis">
        <title>Diagnosis</title>
        <sec id="foxp2-sl-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>A <italic toggle="yes">FOXP2-</italic>related speech and language disorder <bold>should be suspected</bold> in a child with <bold>childhood apraxia of speech (CAS)</bold> [<xref ref-type="bibr" rid="foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</xref>] (also known as developmental verbal dyspraxia, verbal dyspraxia, or speech dyspraxia) and <bold>additional clinical findings</bold>.</p>
          <p>
            <bold>CAS</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Children with CAS have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences.</p>
            </list-item>
            <list-item>
              <p>The diagnosis of CAS is made by assessment by a speech-language pathologist (also known as a speech and language therapist in the UK). CAS is challenging to diagnose in a child younger than age three years: speech development is delayed in these children, and thus key manifestations are typically not seen or able to be elicited until the child has acquired sufficient speech to complete the verbal assessment tasks.</p>
            </list-item>
          </list>
          <p>
            <bold>Additional clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Delayed speech development</p>
            </list-item>
            <list-item>
              <p>Poor oral motor function (e.g., excessive drooling, early feeding difficulties)</p>
            </list-item>
            <list-item>
              <p>Oral motor difficulties and/or oral motor dyspraxia</p>
            </list-item>
            <list-item>
              <p>Dysarthria</p>
            </list-item>
            <list-item>
              <p>Receptive and expressive language impairment</p>
            </list-item>
            <list-item>
              <p>Low average IQ, typically with poorer verbal IQ compared to nonverbal IQ (and average nonverbal IQ reported in some)</p>
            </list-item>
            <list-item>
              <p>Mild dysmorphology may rarely be present</p>
            </list-item>
            <list-item>
              <p>Autistic features may rarely be present</p>
            </list-item>
            <list-item>
              <p>Reading and spelling impairment</p>
            </list-item>
            <list-item>
              <p>Fine and gross motor impairment</p>
            </list-item>
          </list>
        </sec>
        <sec id="foxp2-sl-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">FOXP2-</italic>related speech and language disorder is established in a proband by detection of ONE of the following (see <xref ref-type="table" rid="foxp2-sl-dis.T.molecular_genetic_testing">Table 1</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p>A large non-recurrent contiguous gene deletion that includes <italic toggle="yes">FOXP2</italic> (52% of affected individuals)</p>
            </list-item>
            <list-item>
              <p>A sequence variant within <italic toggle="yes">FOXP2</italic> (~29%)</p>
            </list-item>
            <list-item>
              <p>Maternal uniparental disomy of chromosome 7 (UPD7) that reduces <italic toggle="yes">FOXP2</italic> expression (~11%)</p>
            </list-item>
            <list-item>
              <p>A structural variant (e.g., translocation, inversion) that disrupts <italic toggle="yes">FOXP2</italic> (~8%).</p>
            </list-item>
          </list>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (multi-gene panel or single-gene testing) and <bold>genomic testing</bold> (chromosomal microarray [CMA] and comprehensive genomic sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires the clinician to determine which gene(s) are likely involved, whereas genomic testing may not. Because the phenotype of <italic toggle="yes">FOXP2-</italic>related speech and language disorders is broad, children with the distinctive findings described in <xref ref-type="sec" rid="foxp2-sl-dis.Suggestive_Findings">Suggestive Findings</xref> are likely to be diagnosed using gene-targeted testing (see <bold>Option 1</bold>), whereas a more severe phenotype that includes developmental delay (DD)/intellectual disability (ID) may be indistinguishable from many other inherited disorders with DD/ID and is more likely to be diagnosed using genomic testing (see <bold>Option 2</bold>).</p>
          <p><bold>Option 1. Gene-targeted testing.</bold> When the clinical findings suggest the diagnosis of a <italic toggle="yes">FOXP2-</italic>related speech and language disorder, molecular genetic testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">FOXP2</italic> is performed first, followed by gene-targeted deletion/duplication analysis.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">FOXP2</italic> and other genes of interest (see <xref ref-type="sec" rid="foxp2-sl-dis.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting secondary findings. However, because of the rarity of <italic toggle="yes">FOXP2-</italic>related speech and language disorders, many panels for inherited disorders with developmental delay/intellectual disability may not include this gene. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <p><bold>Methylation testing</bold> for maternal uniparental disomy (UPD) of chromosome 7 should be considered in individuals with verbal dyspraxia and features suggestive of <related-object link-type="booklink" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver syndrome</related-object>, since UPD accounted for about 12% of cases in one study [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>].</p>
          <p>Note: <italic toggle="yes">FOXP2</italic> has not been demonstrated to be an imprinted gene. Although <italic toggle="yes">FOXP2</italic> is located on chromosome 7, the mechanistic relationship between UPD7 and <italic toggle="yes">FOXP2</italic> function has not been established.</p>
          <p><bold>Option 2. Genomic testing.</bold> When the phenotype is indistinguishable from many other inherited disorders with language delay and developmental delay/intellectual disability, molecular genetic testing approaches can include genomic testing (CMA, comprehensive genome sequencing, and karyotype):</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>CMA</bold> should be the first genetic test as about 52% of <italic toggle="yes">FOXP2</italic>-related speech and language disorders are caused by large non-recurrent deletions that encompass <italic toggle="yes">FOXP2</italic> and flanking DNA.</p>
            </list-item>
            <list-item>
              <p><bold>Further testing</bold> to consider:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Comprehensive genome sequencing</bold> (when clinically available) includes exome sequencing and genome sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
                </list-item>
                <list-item>
                  <p><bold>Karyotype.</bold> An apparently balanced translocation or pericentromeric inversion involving <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/mapview/maps.cgi?taxid=9606&#x00026;chr=7&#x00026;query=FOXP2&#x00026;qstr=FOXP2&#x00026;maps=snp,genes-r,pheno&#x00026;zoom=2">7q31.1</ext-link>, the <italic toggle="yes">FOXP2</italic> locus<italic toggle="yes">,</italic> has been observed in about 8% of <italic toggle="yes">FOXP2-</italic>plus-related disorders and <italic toggle="yes">FOXP2-</italic>only-related disorders.</p>
                </list-item>
              </list>
              <p>Note: A multi-gene panel for inherited disorders of speech delay and developmental delay/intellectual disability may be considered.</p>
            </list-item>
          </list>
          <table-wrap id="foxp2-sl-dis.T.molecular_genetic_testing" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">FOXP2-</italic>Related Speech and Language Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2">Test Method</th>
                  <th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1"><italic toggle="yes">FOXP2</italic>-plus</th>
                  <th headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">FOXP2-</italic>only</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">FOXP2</italic>
                  </td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CMA&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">34/65 (52%)&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">19/65 (29%)&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Methylation testing (to detect UPD)</td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">7/65 (~11%)&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Karyotype (to detect structural variants)</td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">5/65 (~8%)&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">Unknown</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="foxp2-sl-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="foxp2-sl-dis" object-id="foxp2-sl-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="foxp2-sl-dis.Molecular_Genetics">Molecular Genetics</xref> and <xref ref-type="table" rid="foxp2-sl-dis.T.foxp2_pathogenic_variants">Table 3</xref> for information on reported genetic alterations and phenotypes.</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.3">
                <label>3. </label>
                <p>Deletion/duplication analysis (genomic approach) detects deletion of <italic toggle="yes">FOXP2</italic> and other contiguous genes using a chromosomal microarray (CMA) that specifically includes this gene/chromosome segment.</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.4">
                <label>4. </label>
                <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/clingen_gene.cgi?sym=foxp2&#x00026;subject=">ClinGen-19248</ext-link>. Standardized clinical annotation and interpretation for genomic variants from the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicalgenome.org/about/">Clinical Genome Resource (ClinGen) project</ext-link> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium).</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al [2006]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al [2007]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.palka.2012.e183">Palka et al [2012]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al [2012]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al [2012]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.adegbola.2015.6848">Adegbola et al [2015]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</xref></p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.6">
                <label>6. </label>
                <p>One affected individual had mosaicism for a large deletion [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.palka.2012.e183">Palka et al 2012</xref>].</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.7">
                <label>7. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice-site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al [2005]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.roll.2010.4848">Roll et al [2010]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al [2012]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al [2013]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</xref></p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</xref>
                </p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.10">
                <label>10. </label>
                <p><xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2000.357">Lai et al [2000]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al [2006]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al [2009]</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.moralli.2015.36">Moralli et al [2015]</xref></p>
              </fn>
              <fn id="foxp2-sl-dis.TF.1.11">
                <label>11. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="foxp2-sl-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="foxp2-sl-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">FOXP2-</italic>related speech and language disorders &#x02013; regardless of the underlying genetic alteration &#x02013; have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. Individuals with CAS (whether caused by an alteration of <italic toggle="yes">FOXP2</italic> or of an unknown cause) have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in <italic toggle="yes">FOXP2</italic>-related speech disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; reading and spelling impairments; more preserved non-verbal IQ compared to verbal IQ; and fine motor difficulties. &#x02018;Autistic features&#x02019; or a diagnosis of autism spectrum disorder (ASD) has been reported in some, but not all cases. Similarly typically mild dysmorphology has been reported in a few cases only.</p>
          <p>The underlying genetic alteration of <italic toggle="yes">FOXP2-</italic>related speech and language disorders is one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Disruption of <italic toggle="yes">FOXP2</italic> only &#x02013; here referred to as <italic toggle="yes">FOXP2</italic>-only-related speech and language disorders</p>
            </list-item>
            <list-item>
              <p>Large copy number variants (i.e., contiguous gene deletions) or structural variants (i.e., translocation or inversion) involving <italic toggle="yes">FOXP2</italic> &#x02013; here referred to as <bold><italic toggle="yes">FOXP2</italic>-plus speech and language disorders</bold></p>
            </list-item>
          </list>
          <p>The genetic alteration determines if only speech and language problems are present (<italic toggle="yes">FOXP2</italic>-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (<italic toggle="yes">FOXP2</italic>-plus speech and language disorder).</p>
          <p>In <italic toggle="yes">FOXP2-</italic>only<italic toggle="yes">-</italic>related disorders nonverbal (performance) IQ is typically relatively preserved compared to verbal IQ and gross motor skills are normal. In <italic toggle="yes">FOXP2-</italic>plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorders are commonly seen.</p>
          <p>To date, available evidence suggests that heterozygous pathogenic variants in <italic toggle="yes">FOXP2</italic> (including whole- or partial-gene deletions) cause the motor speech disorder known as childhood apraxia of speech (CAS) which interferes non-selectively with multiple aspects of language, including phonology, grammar, and literacy. The interactions between these communication disorder subtypes are not well understood. Language and literacy difficulties may be influenced by or even result from CAS, or these phenotypes may actually be features of the same broad communication disorder.</p>
          <p><bold>Childhood apraxia of speech</bold> (CAS), a disorder of speech motor planning/programming, is the core phenotype of <italic toggle="yes">FOXP2-</italic>related speech and language disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>].</p>
          <p>CAS affects the production, sequencing, timing, and stress of sounds, syllables, and words [<xref ref-type="bibr" rid="foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</xref>]; thus, children with CAS have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with appropriate prosody.</p>
          <p>First words are reported to appear between ages 18 months and seven years in children with <italic toggle="yes">FOXP2-</italic>only-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>] and <italic toggle="yes">FOXP2-</italic>plus-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</xref>]. <italic toggle="yes">FOXP2-</italic>related speech and language disorders are typically diagnosed around age three to four years, but may be considered earlier when the family history is positive.</p>
          <p>In the first decade of life, speech is highly unintelligible, even to close friends and family. Although speech development and intelligibility improve over time, speech never develops to the same level as age-matched peers; intelligibility may remain reduced even in the third and fourth decades of life [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.fee.1995.189">Fee 1995</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al 2006</xref>]. Note: The <xref ref-type="bibr" rid="foxp2-sl-dis.REF.fee.1995.189">Fee [1995]</xref> study of members of the KE family was conducted prior to the identification of a causative <italic toggle="yes">FOXP2</italic> heterozygous pathogenic variant in affected family members by <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</xref>.</p>
          <p>In contrast, for typically developing children, speech sound acquisition is mastered by around age eight years [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.dodd.2003.617">Dodd et al 2003</xref>] with intelligibility as high as 97% as early as age three years [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.flipsen.2006.303">Flipsen 2006</xref>].</p>
          <p>Although CAS comprises certain core features, it is important to note that the severity and features of CAS change across the life span [<xref ref-type="bibr" rid="foxp2-sl-dis.REF33">Royal College of Speech and Language Therapists 2011</xref>] and while referred to as &#x02018;core&#x02019; features, they are not necessarily present in all individuals with CAS [<xref ref-type="bibr" rid="foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</xref>]. Core features, agreed upon by a consensus panel, include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Inconsistent speech errors (e.g., producing the same syllable or word differently across repetitions of the same word such as &#x0201c;ubella,&#x0201d; &#x0201c;umbrella,&#x0201d; &#x0201c;umbarella&#x0201d; for umbrella)</p>
            </list-item>
            <list-item>
              <p>Lengthened and disrupted co-articulatory transitions (e.g., oral groping behaviors during speech; difficulty sequencing phonemes and syllables; difficulty maintaining syllable integrity; hypernasality [thought to be due to incoordination of velum for denoting oral/nasal contrasts]; slowed and disrupted diadochokinetic sequences [e.g., when asked to repeat &#x0201c;pa-ta-ka&#x0201d;])</p>
            </list-item>
            <list-item>
              <p>Inappropriate prosody (e.g., lexical stress errors, equal stress across words giving a robotic-sounding presentation)</p>
            </list-item>
          </list>
          <p>In addition, children with CAS tend to lag behind their peers in acquiring the sounds of their language system; hence, their phonetic inventory may be reduced for the child&#x02019;s age. Children with CAS may use a more restricted range of consonants and vowels than age-matched peers. For example, they will simplify syllable shapes, reducing a consonant-consonant-vowel shape (CCV) (e.g., &#x0201c;sta&#x0201d;) or a CCCV shape (&#x0201c;stra&#x0201d;) to a consonant-vowel (CV) shape (&#x0201c;sa&#x0201d;).</p>
          <p>Although CAS is distinct from other speech disorders (e.g., stuttering, phonologic disorder) and language disorders (e.g., specific language impairment), these additional diagnoses can technically co-occur with CAS.</p>
          <p><bold>Additional common speech- and language-related comorbidities</bold> in <italic toggle="yes">FOXP2-</italic>related speech and language disorders can include the following &#x02013; irrespective of underlying genetic alteration:</p>
          <list list-type="bullet">
            <list-item>
              <p>Oral motor dyspraxia, an inability or difficulty in planning or programming of oral movements on command, including single movements in isolation (e.g., commands such as &#x02018;blow&#x02019;; &#x02018;bite&#x02019;; &#x02018;stick out your tongue&#x02019;) or sequences of oral movements (e.g., commands such as &#x02018;bite and blow&#x02019;; &#x02018;touch your bottom lip with your tongue and then your top lip&#x02019;). Oral dyspraxia has been more commonly reported than oral motor deficits per se in <italic toggle="yes">FOXP2-</italic>only-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.1998.12695">Vargha-Khadem et al 1998</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.alcock.2000.17">Alcock et al 2000</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2000.357">Lai et al 2000</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>], in contrast to <italic toggle="yes">FOXP2</italic>-plus-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Dysarthria, which is typically classified as spastic [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.morgan.2010">Morgan et al 2010</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>]. Typical dysarthric features include hypernasality, impaired laryngeal quality, and difficulties modulating pitch and loudness.</p>
            </list-item>
            <list-item>
              <p>Moderate to severe receptive and expressive language disorder [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al 2009</xref>]. Expressive language is usually poorer than receptive language, with expressive language likely confounded by the presence of CAS. Impaired performance across both semantic and syntactic language domains has been reported in <italic toggle="yes">FOXP2</italic>-related speech and language disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>]. Affected  semantic domains include naming accuracy and lexical decision making; affected  syntactic domains include past tense production for regular and irregular verbs.</p>
            </list-item>
            <list-item>
              <p>Reading and spelling impairments, which are evident once literacy develops [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</xref>]. Difficulties with real word and non-word reading, spelling, and phonologic awareness skills have been noted in some individuals with <italic toggle="yes">FOXP2</italic>-related speech and language disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>]. Of note, the literacy skills of affected individuals have rarely been discussed in case reports and &#x02013; given the link between speech and literacy disorders &#x02013; deficits are likely to be underrecognized.</p>
            </list-item>
          </list>
          <p>
            <bold>Other features of <italic toggle="yes">FOXP2-</italic>only<italic toggle="yes">-</italic>related disorders</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Generally stronger nonverbal (performance) IQ compared to verbal IQ [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>] and compared to children with <italic toggle="yes">FOXP2</italic>-plus-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al 2009</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</xref>]. Based on data from the largest family reported to date (which also has the most comprehensive IQ phenotyping available), it appears that in addition to lower verbal IQ (presumably affected by CAS and comorbid expressive language deficits), nonverbal (performance) IQ may also be lower than average in some areas (e.g., coding subtest; see <xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al [2002)</xref>. Further, relative strengths in nonverbal IQ have been previously reported in block design and object assembly subtests of IQ measures [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>], notably tasks relying on visual processing.</p>
            </list-item>
            <list-item>
              <p>Normal fine and gross motor skills are seen in some affected individuals [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2001.519">Lai et al 2001</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</xref>] but others with FOXP2-only disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>], or <italic toggle="yes">FOXP2</italic>-plus-related disorders [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</xref>] have fine motor deficits. Fine or gross motor impairments are reported as relatively mild compared to the marked speech production deficits [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2000.357">Lai et al 2000</xref>]. Overall however, relatively little attention has been given in the literature to the possible presence of general motor deficits.</p>
            </list-item>
            <list-item>
              <p>Some features of ASD have been observed and formal diagnoses of ASD have been made in a small number of recently reported individuals; however, the data suggest that these behavioral issues are not a core feature [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>].</p>
            </list-item>
            <list-item>
              <p>Mild dysmorphology reported in a small number of individuals, included high arch palate, horizontal eyebrows, simply folded ears [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>] submucous cleft palate was reported in one individual [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.li_geois.2016.35192">Li&#x000e9;geois et al 2016</xref>]</p>
            </list-item>
          </list>
          <p>
            <bold>Other features of <italic toggle="yes">FOXP2</italic>-plus-related disorders</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Oral motor deficits commonly reported [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>&#x02018;Global&#x02019; developmental delay (presumably involving speech, cognitive, gross, and fine motor abilities) [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Autism spectrum disorder (ASD) [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</xref>] or presence of features of ASD such as repetitive behaviors and unusual interests [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</xref>]. Of note, many individuals with <italic toggle="yes">FOXP2-</italic>only-related disorders are explicitly stated not to meet diagnostic criteria for ASD [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</xref>], suggesting that these features may relate to disruption of neighboring genes on chromosome 7.</p>
            </list-item>
            <list-item>
              <p>Facial dysmorphology [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</xref>]. Oral structures are typically intact in the absence of a cleft lip or palate, but a high arched palate has been reported in one individual [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.palka.2012.e183">Palka et al 2012</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <p>Clinical brain MRIs of individuals with a <italic toggle="yes">FOXP2</italic>-related speech and language disorder reportedly appear normal on visual inspection [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.1998.12695">Vargha-Khadem et al 1998</xref>].</p>
          <p>In contrast, sophisticated quantitative MRI data acquisition and analysis techniques suggest that bilateral subcortical volume reductions are strong markers of <italic toggle="yes">FOXP2</italic> disruption in childhood based on findings in (1) members of the KE family with the <italic toggle="yes">FOXP2</italic> pathogenic variant p.Arg553His compared to unaffected family members [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</xref>] and (2) one individual with the <italic toggle="yes">FOXP2</italic> pathogenic variant Gln415ValfsTer5 [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.li_geois.2016.35192">Li&#x000e9;geois et al 2016</xref>]. Because data are limited further studies are required to understand the generalizability of this finding.</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="foxp2-sl-dis-neuroimaging.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for detailed information on neuroimaging findings in the KE family, the first (and largest) family for which published imaging data are reported.</p>
        </sec>
        <sec id="foxp2-sl-dis.GenotypePhenotype_Correlati">
          <title>Genotype-Phenotype Correlations</title>
          <p>The specific genetic alteration responsible for a <italic toggle="yes">FOXP2</italic>-related speech and language disorder does not predict clinical severity. However, the phenotype of <italic toggle="yes">FOXP2-</italic>plus-related disorders tends to be more severe overall (given the increased risk for the additional clinical features of global developmental delay and a formal diagnosis of autism spectrum disorder) compared to the phenotype of <italic toggle="yes">FOXP2-</italic>only<italic toggle="yes">-</italic>related disorders. See <xref ref-type="table" rid="foxp2-sl-dis.T.foxp2_pathogenic_variants">Table 3</xref> for reported genetic alterations and phenotypes.</p>
        </sec>
        <sec id="foxp2-sl-dis.Penetrance">
          <title>Penetrance</title>
          <p>The penetrance for this severe speech and language disorder is high, close to 100% based on reported cases.</p>
        </sec>
        <sec id="foxp2-sl-dis.Nomenclature">
          <title>Nomenclature</title>
          <p>Prior to the discovery of <italic toggle="yes">FOXP2,</italic> the locus &#x0201c;speech language disorder-1 (SPCH1)&#x0201d; was assigned to the chromosome region linked to the CAS phenotype [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.fisher.1998.168">Fisher et al 1998</xref>]<italic toggle="yes">.</italic></p>
        </sec>
        <sec id="foxp2-sl-dis.Prevalence">
          <title>Prevalence</title>
          <p>The population prevalence of childhood apraxia of speech (CAS) has not been determined by any epidemiologic study. The most commonly referenced estimate of prevalence is 1-2:1000 population [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.1997.273">Shriberg et al 1997</xref>]. Of note, no data are available to determine what proportion of CAS is caused by disruption of <italic toggle="yes">FOXP2</italic> only or large copy number variants or structural variants involving <italic toggle="yes">FOXP2.</italic></p>
          <p>In a cohort with a severe speech disorder, one of 49 individuals had a confirmed <italic toggle="yes">FOXP2</italic>-related speech and language disorder, whereas a previously unreported <italic toggle="yes">FOXP2</italic> variant of uncertain clinical significance was detected in two additional unrelated individuals [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</xref>].</p>
          <p>In an independent cohort with a CAS diagnosis, a previously unreported <italic toggle="yes">FOXP2</italic> variant of uncertain clinical significance was detected in one of 24 individuals [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</xref>].</p>
          <p>Of note, beyond these studies of CAS, other studies of cohorts with different disorders of speech and language development have not reported individuals with pathogenic <italic toggle="yes">FOXP2</italic> coding variants (e.g., see <xref ref-type="bibr" rid="foxp2-sl-dis.REF.han.2014.23">Han et al [2014]</xref> for a study of developmental stuttering, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.gauthier.2003.172">Gauthier et al [2003]</xref> for a study of autistic disorder, and <xref ref-type="bibr" rid="foxp2-sl-dis.REF.newbury.2002.1318">Newbury et al [2002]</xref> for a study of autism and specific language impairment).</p>
        </sec>
      </sec>
      <sec id="foxp2-sl-dis.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">FOXP2</italic>.</p>
      </sec>
      <sec id="foxp2-sl-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The prelinguistic developmental history of children with childhood apraxia of speech (CAS) (e.g., restricted babbling or feeding difficulties) is very similar to that seen in other neurodevelopmental speech or language conditions (e.g., specific language impairment, phonologic disorder) or even other neurodevelopmental disorders in which language impairment may occur such as autism spectrum disorders (ASDs). Hence, early signs are not usually sufficiently discriminating to enable a differential diagnosis prior to a child gaining some speech production abilities.</p>
        <p>The primary feature of the <italic toggle="yes">FOXP2</italic>-related speech and language disorders is CAS, a rare diagnosis. Other developmental speech and language disorders, such as stuttering and phonologic production disorder, are distinguishable on a speech and language assessment.</p>
        <p>While CAS is rare, it may also be observed in a range of other conditions. The following may be considered in the differential diagnosis.</p>
        <p><bold>Unknown cause of CAS.</bold> Although the clinical manifestations and developmental history of children with CAS of unknown cause is almost indistinguishable from that of children with <italic toggle="yes">FOXP2</italic>-related CAS, speech prognosis appears poorer for individuals with <italic toggle="yes">FOXP2</italic>-related CAS. No studies have systematically compared the two populations.</p>
        <p><bold>Known causes of CAS.</bold> Disorders to consider in the differential diagnosis of <italic toggle="yes">FOXP2</italic>-related speech and language disorders are listed in <xref ref-type="table" rid="foxp2-sl-dis.T.disorders_to_consider_in">Table 2</xref><bold>.</bold> The clinical features of these disorders vary; most can be diagnosed by chromosomal microarray (CMA).</p>
        <table-wrap id="foxp2-sl-dis.T.disorders_to_consider_in" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of <italic toggle="yes">FOXP2</italic>-Related Speech and Language Disorders</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Name</th>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">Gene</italic> or Critical Region</th>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">MOI</th>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CAS</th>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Overlapping Clinical Features<break/>(in addition to CAS)</th>
                <th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing Clinical Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="del16p11_2" document-type="chapter">16p11.2 microdeletion</related-object>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AUTS14</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD&#x000a0;<sup>1,&#x000a0;2</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Intellectual disability</p></list-item><list-item><p>Autism spectrum disorder</p></list-item><list-item><p>Developmental delay</p></list-item><list-item><p>Expressive language skills more severely impaired than receptive language</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Epilepsy or recurrent seizures</p></list-item><list-item><p>Dysmorphic features (e.g., low-set ears, partial syndactyly)</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="dup7q11_23" document-type="chapter">7q11.23 duplication syndrome</related-object>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">WBSCR</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Developmental delay</p></list-item><list-item><p>Appropriate nonverbal pragmatic abilities in socially comfortable situations</p></list-item><list-item><p>Oral apraxia</p></list-item><list-item><p>Phonologic disorder</p></list-item><list-item><p>Expressive language disorder</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Hypotonia</p></list-item><list-item><p>Dysmorphic features (brachycephaly, broad forehead, straight eyebrows, broad nasal tip, low insertion of the columella, short philtrum, thin upper lip, minor ear anomalies, facial asymmetry)</p></list-item><list-item><p>Social anxiety</p></list-item><list-item><p>Developmental coordination disorder</p></list-item><list-item><p>In some:</p></list-item><list-item><p>Macrocephaly</p></list-item><list-item><p>Visually detectable MRI abnormalities (e.g., vermis hypoplastic, ventriculomegaly, vermis hypoplasia)</p></list-item><list-item><p>Signs of cerebellar dysfunction</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mdel17q21_31" document-type="chapter"><italic toggle="yes">KANSL1</italic>-related intellectual disability syndrome</related-object>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">KANSL1</italic>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Early oral motor and feeding difficulties</p></list-item><list-item><p>Developmental delay</p></list-item><list-item><p>Oral dyspraxia</p></list-item><list-item><p>Expressive language abilities better than receptive language</p></list-item><list-item><p>Literacy problems</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Intellectual disability</p></list-item><list-item><p>Hypotonia</p></list-item><list-item><p>Dysmorphic features (elongated face, bulbous nasal tip)</p></list-item><list-item><p>Seizures</p></list-item><list-item><p>Visual and/or hearing deficits</p></list-item><list-item><p>Heart problems</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">GRIN2A</italic>-related disorders&#x000a0;<sup>4</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/245570">OMIM</ext-link></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GRIN2A</italic>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Oral dyspraxia</p></list-item><list-item><p>Dysarthria</p></list-item><list-item><p>Aphasia</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Epilepsy</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Worster-Drought syndrome&#x000a0;<sup>5</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/185480">OMIM</ext-link></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Cerebral palsy&#x000a0;<sup>6</sup></p></list-item><list-item><p>Oral dyspraxia</p></list-item><list-item><p>Dysarthria</p></list-item><list-item><p>Mild fine and gross movement difficulties</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Epilepsy</p></list-item><list-item><p>Moderate learning difficulties</p></list-item><list-item><p>Club feet</p></list-item><list-item><p>Restricted joint movement</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="fhs" document-type="chapter">Floating-Harbor syndrome</related-object>&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SRCAP</italic>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Dysarthria</p></list-item><list-item><p>Hypernasality</p></list-item><list-item><p>Severe expressive &#x00026; receptive language &#x00026; literacy impairments</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Short stature</p></list-item><list-item><p>Delayed bone age</p></list-item><list-item><p>Characteristic facies</p></list-item><list-item><p>Aggression in childhood</p></list-item></list>
</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="galactosemia" document-type="chapter">Galactosemia</related-object>&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GALT</italic>
                </td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+&#x000a0;<sup>9</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Expressive/receptive language impairments</p></list-item><list-item><p>Typical or borderline-low IQ to more severe IQ depending on type of galactosemia&#x000a0;<sup>10</sup></p></list-item><list-item><p>Dysarthria</p></list-item></list>
</td>
                <td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Movement coordination disorder, primarily affecting balance &#x00026; manual dexterity</p></list-item><list-item><p>Voice dysfunction</p></list-item><list-item><p>Liver function issues</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>CAS = childhood apraxia of speech</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.1">
              <label>1. </label>
              <p>Most pathogenic variants are <italic toggle="yes">de novo</italic> in the proband.</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.fedorenko.2016.310">Fedorenko et al [2016]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.velleman.2011.108">Velleman &#x00026; Mervis [2011]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.4">
              <label>4. </label>
              <p>Landau Kleffner syndrome and epilepsy-aphasia syndromes</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.5">
              <label>5. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.clark.2000.2160">Clark et al [2000]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.6">
              <label>6. </label>
              <p>Cerebral palsy may be associated with brain damage or malformation such as bilateral perisylvian polymicrogyria (excessive and small gyri).</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.white.2010.821">White et al [2010]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.8">
              <label>8. </label>
              <p>The prevalence of motor speech disorder in this group is high; in one study ~25% of children had CAS [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.2011.487">Shriberg et al 2011</xref>].</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.9">
              <label>9. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.potter.2013.31">Potter et al [2013]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.2.10">
              <label>10. </label>
              <p>Individuals with the Gln188Arg/Gln188Arg genotype may be at increased risk for cognitive and language impairments.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="foxp2-sl-dis.Management">
        <title>Management</title>
        <sec id="foxp2-sl-dis.Evaluations_Following_Initi">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and management needs for an individual with a <italic toggle="yes">FOXP2-</italic>related speech and language disorder, the following evaluations conducted by a trained and specialized speech-language pathologist are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Detailed developmental history including early oral motor and feeding abilities, speech sound development, motor milestones, and cognitive development</p>
            </list-item>
            <list-item>
              <p>Family history of speech disorder</p>
            </list-item>
            <list-item>
              <p>Oral-facial structural examination to determine if any structural abnormalities are present</p>
            </list-item>
            <list-item>
              <p>Assessment of oral motor function including:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Examination of cranial nerve function for evidence of asymmetry, reduced or increased tone, and/or poor coordination of neuromuscular movements</p>
                </list-item>
                <list-item>
                  <p>Examination for evidence of oral motor dyspraxia (e.g., can the patient perform oral movements on command in isolation [e.g., &#x02018;bite&#x02019; or &#x02018;blow&#x02019;] or in sequence [e.g., &#x02018;kiss and blow&#x02019;; &#x02018;kiss, blow, and bite&#x02019;])</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Speech sound assessment including a test of single words, sounds in isolation, and connected speech to determine the child&#x02019;s phonetic inventory (i.e., has the child acquired age-appropriate speech sounds) and to determine if the child has articulation errors, phonologic errors, apraxic errors, dysarthric errors, or a combination of these errors. The presence of resonance or nasality deficits signals the need to consider whether such structurally based velopharyngeal port incompetence is present by referral to an ear, nose, and throat specialist and possibly videopalatography.</p>
            </list-item>
            <list-item>
              <p>Language assessment to determine the presence of receptive and/or expressive language impairments across the domains of semantics, syntax, and morphology</p>
            </list-item>
            <list-item>
              <p>Literacy assessment or pre-literacy (phonologic awareness) for evidence of reading and spelling difficulties</p>
            </list-item>
            <list-item>
              <p>Social skills assessment for the presence of autistic features</p>
            </list-item>
          </list>
          <p>Additional evaluations:</p>
          <list list-type="bullet">
            <list-item>
              <p>Referral to a neuropsychologist or clinical psychologist to determine the extent of any coexisting cognitive and learning impairments and to examine for the presence of behaviors associated with autism spectrum disorder</p>
            </list-item>
            <list-item>
              <p>Referral to a physiotherapist if gross motor movement difficulties are reported and an occupational therapist if fine motor movement difficulties are observed</p>
            </list-item>
            <list-item>
              <p>Consideration of MRI to evaluate for the presence of a neurologic lesion if indicated</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="foxp2-sl-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Speech and language deficits</bold>. A speech pathologist will utilize treatments targeted to the specific findings in an affected individual; hence, the importance of a thorough initial assessment to establish the extent of disease and management needs for an individual. No single recommended treatment exists.</p>
          <p>The optimal approach should be determined based on the individual&#x02019;s findings regarding:</p>
          <list list-type="bullet">
            <list-item>
              <p>CAS [<xref ref-type="bibr" rid="foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.morgan.2008.cd006278">Morgan &#x00026; Vogel 2008</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF33">Royal College of Speech and Language Therapists 2011</xref>];</p>
            </list-item>
            <list-item>
              <p>Dysarthria [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.pennington.2009.cd006937">Pennington et al 2009</xref>];</p>
            </list-item>
            <list-item>
              <p>Language deficits [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.law.2003.cd004110">Law et al 2003</xref>];</p>
            </list-item>
            <list-item>
              <p>Literacy impairments [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.snowling.2012.27">Snowling &#x00026; Hulme 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Cognitive deficits</bold>. A clinical psychologist or neuropsychologist may provide strategies to help manage deficits in specific cognitive or social skill domains.</p>
          <p><bold>Fine and gross motor deficits.</bold> An occupational therapist and physiotherapist can provide strategies to help with these issues.</p>
        </sec>
        <sec id="foxp2-sl-dis.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine care by a general pediatrician</p>
            </list-item>
            <list-item>
              <p>Follow-up evaluations with standardized tests by a speech and language pathologist</p>
            </list-item>
          </list>
        </sec>
        <sec id="foxp2-sl-dis.Evaluation_of_Relatives_at">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic sibs of an affected individual by molecular genetic testing of the <italic toggle="yes">FOXP2</italic> genetic alteration in the family to identify as early as possible those who would benefit from prompt evaluation and initiation of treatment.</p>
          <p>See <xref ref-type="sec" rid="foxp2-sl-dis.Genetic_Counseling">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="foxp2-sl-dis.Therapies_Under_Investigati">
          <title>Therapies Under Investigation</title>
          <p>A number of therapies for childhood apraxia of speech (CAS) are under investigation [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.morgan.2008.cd006278">Morgan &#x00026; Vogel 2008</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.murray.2014.486">Murray et al 2014</xref>, <xref ref-type="bibr" rid="foxp2-sl-dis.REF.murray.2015">Murray et al 2015</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="foxp2-sl-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="foxp2-sl-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Genetic counseling for a <italic toggle="yes">FOXP2-</italic>related speech and language disorders depends on the causative genetic alteration:</p>
          <list list-type="bullet">
            <list-item>
              <p>Large non-recurrent contiguous gene deletion that includes <italic toggle="yes">FOXP2</italic>; 80% are <italic toggle="yes">de novo</italic> and the remainder are inherited in an autosomal dominant manner (see <xref ref-type="table" rid="foxp2-sl-dis.T.foxp2_pathogenic_variants">Table 3</xref>).</p>
            </list-item>
            <list-item>
              <p>Sequence variant within <italic toggle="yes">FOXP2</italic>; ~70% are <italic toggle="yes">de novo</italic> and the remainder are inherited in an autosomal dominant manner.</p>
            </list-item>
            <list-item>
              <p>Maternal uniparental disomy of chromosome 7 (UPD7); recurrence risk is not increased over that of the general population.</p>
            </list-item>
            <list-item>
              <p>Structural variant (e.g., chromosome translocation, inversion) that disrupts <italic toggle="yes">FOXP2</italic>; recurrence risk depends on the specific structural variant.</p>
            </list-item>
          </list>
        </sec>
        <sec id="foxp2-sl-dis.Risk_to_Family_Members__Lar">
          <title>Risk to Family Members &#x02013; Large Non-Recurrent Contiguous Gene Deletion including <italic toggle="yes">FOXP2</italic></title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a proband with a contiguous gene deletion are generally unaffected.</p>
            </list-item>
            <list-item>
              <p>The majority of deletions are <italic toggle="yes">de novo</italic> [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Evaluation of the parents by genomic testing that will detect the deletion identified in the proband is recommended.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of a proband depends on the genetic status of the parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the deletion found in the proband is not identified in one of the parents, the presumed risk to sibs is low (&#x0003c;1%) but greater than that of the general population because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If one of the parents has the deletion identified in the proband, the risk to each sib of inheriting the deletion is 50%; however, it is not possible to reliably predict clinical severity in sibs who inherit the deletion.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold> have a 50% chance of inheriting the deletion; however, it is not possible to reliably predict clinical severity in offspring who inherit the deletion.</p>
        </sec>
        <sec id="foxp2-sl-dis.Risk_to_Family_Members__Seq">
          <title>Risk to Family Members &#x02013; Sequence Variant within <italic toggle="yes">FOXP2</italic></title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>30% of individuals with a sequence variant within <italic toggle="yes">FOXP2</italic> have an affected parent<italic toggle="yes">.</italic></p>
            </list-item>
            <list-item>
              <p>70% of individuals with a <italic toggle="yes">FOXP2</italic> sequence variant have a <italic toggle="yes">de novo</italic> variant.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with a <italic toggle="yes">FOXP2</italic> pathogenic variant to determine if the variant was inherited or is <italic toggle="yes">de novo</italic> in the proband.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">FOXP2</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic>
<italic toggle="yes">FOXP2</italic> pathogenic variant in the proband or germline mosaicism in a parent.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the proband&#x02019;s parents:</p>
              <list list-type="bullet">
                <list-item>
                  <p>If a parent of the proband has the <italic toggle="yes">FOXP2</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%.</p>
                </list-item>
                <list-item>
                  <p>If the <italic toggle="yes">FOXP2</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental germline mosaicism.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold> have a 50% chance of inheriting the <italic toggle="yes">FOXP2</italic> sequence variant.</p>
        </sec>
        <sec id="foxp2-sl-dis.Risk_to_Family_Members__Str">
          <title>Risk to Family Members &#x02013; Structural Variant</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of the parents by karyotyping that will detect the structural variant present in the proband is recommended.</p>
            </list-item>
            <list-item>
              <p>The proportion of parents carrying a structural variant is not known.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If one of the parents has the structural variant identified in the proband, the risk to sibs is increased and depends on the specific structural variant.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Risk to offspring depends on the specific structural variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband&#x02019;s parents: if a parent has the <italic toggle="yes">FOXP2</italic> genetic alteration, his or her family members may be at risk.</p>
        </sec>
        <sec id="foxp2-sl-dis.Related_Genetic_Counseling">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="foxp2-sl-dis.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations when a proband represents an apparently simplex case.</bold> When neither parent of a proband with an autosomal dominant disorder has the genetic alteration identified in the proband, the genetic alteration is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk of having a child with a <italic toggle="yes">FOXP2</italic>-related speech and language disorder.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="foxp2-sl-dis.Prenatal_Testing_and_Preimp">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the genetic alteration causative of a <italic toggle="yes">FOXP2-</italic>related speech and language disorder has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis (PGD) are possible.</p>
          <p>Note: While prenatal testing and PGD can be used to detect a familial genetic alteration associated with a <italic toggle="yes">FOXP2</italic>-plus-related disorder or a <italic toggle="yes">FOXP2</italic>-only-related disorder, severity of the phenotype cannot be predicted on the basis of test results.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="foxp2-sl-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="foxp2-sl-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Of the 18 <italic toggle="yes">FOXP2</italic> transcripts reported on <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ensembl.org/">Ensembl</ext-link>, 13 are protein coding. The canonic transcript according to Ensembl (CCDS43635; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898">NM_148898</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_683696">NP_683696</ext-link>) is 6443 base pairs long, encodes 740 amino acids, and consists of 18 exons, 17 of which contain coding sequence.</p>
        <p>The most commonly referenced isoform in the literature (CCDS5760; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_014491">NM_014491</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NP_055306">NP_055306</ext-link>) is 2638 base pairs long, encodes 715 amino acids, and consists of 17 exons, 16 of which contain coding sequence. Given its high expression in human tissues, this isoform is most frequently used for variant nomenclature.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants associated with <italic toggle="yes">FOXP2-</italic>related disorders and the reported phenotypes are summarized in <xref ref-type="table" rid="foxp2-sl-dis.T.foxp2_pathogenic_variants">Table 3</xref>.</p>
        <table-wrap id="foxp2-sl-dis.T.foxp2_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">FOXP2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_014491">NM_014491</ext-link><break/>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898">NM_148898</ext-link>)</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Change<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NP_055306">NP_055306</ext-link><break/>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_683696">NP_683696</ext-link>)</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"># Cases</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sex</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Ethnicity</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Speech</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Oromotor</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Language &#x00026; Literacy</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cognition</th>
                <th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" colspan="11" align="left" scope="col" rowspan="1">
                  <bold>Intragenic <italic toggle="yes">FOXP2</italic> variants&#x000a0;<sup>1</sup></bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.50A&#x0003e;T<break/>(50A&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln17Leu&#x000a0;<sup>2</sup><break/>(Gln17Leu)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Northern European</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.562_573ins12<break/>(637_648ins12)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln188_Gln191dup&#x000a0;<sup>2</sup><break/>(Gln213_Gln216dup)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Northern European</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.982C&#x0003e;T<break/>(1057C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg328Ter&#x000a0;<sup>2</sup><break/>(Arg353Ter)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">2y-4y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M<break/>2F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Northern European</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS,<break/>nonverbal,<break/>poor clarity</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oropharyngeal<break/>dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive, <break/>simple <break/>grammar</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Comprehension difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Motor dyspraxia</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.982C&#x0003e;T<break/>(1057C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg328Ter<break/>(Arg353Ter&#x000a0;<sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1. 14y, 2. 35y (Mo)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M, F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">1: CAS, &#x02018;slurred articulation&#x02019;<break/>2: History of stuttering, CAS, &#x00026; learning difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">1: Severe receptive &#x00026; expressive language deficit; spoke in simple sentences<break/>2: NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">1: NVIQ low normal range at 8y; FSIQ borderline at 14y3m<break/>2: NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">1. Friendly disposition; school for special needs; normal EEG; Morphology: high nasal root; pointed nasal tip, prominent incisors, an overbite, tapering fingers &#x00026; broad feet<break/>2. NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1168_1169delCA<break/>(1243_1244delCA)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln390Valfs<break/>(Gln415Valfs&#x000a0;<sup>4</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">8y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Australian</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oral-motor <break/>apraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Severely <break/>impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Borderline IQ</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1432C&#x0003e;T<break/>(1507C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg478Ter<break/>(Arg503Ter&#x000a0;<sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1. 4.5y, 2. 6.5y, 3. 36y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F, 2M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Philippines</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">1. NR<break/>2. NR<break/>3. Slurred articulation</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">1. &#x02018;Mild delay&#x02019;, 3-word sentences at 4.5 y<break/>2. &#x02018;Severe delay&#x02019;, 5 words at 6.5 y<break/>3. Limited development beyond first words at 7 years; speaks simple sentences; can &#x02018;read &#x00026; write well&#x02019;</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">1. Delayed motor development: mildly backwards, rotated, relatively large ears with uplifted earlobes and horizontal eyebrows;<break/>2. Abnormal hair whorls, backwards rotated relatively large ears with uplifted earlobes, horizontal eyebrows, wide intermammillary distance and fetal pads (fingers &#x00026; toes);<break/>3. Horizontal eyebrows and mildly uplifted earlobes; disability pension, lives with parents.</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1432C&#x0003e;T<break/>(1507C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg478Ter<break/>(Arg503Ter <sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">6y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Persistent speech impairment 6y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Good grades in German language class &#x00026; written tests</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Limited auditory memory capacity; good at maths; ongoing speech and occupational therapies; narrow palpebral fissures, high arched palate, mild finger pads, EEG normal, audiometry normal; strabismus, hyperopia, astigmatism</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1514C&#x0003e;T<break/>(1589C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro505Leu<break/>(Pro530Leu <sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1. 6.5y; 2. 40y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">1. German-Thai;<break/>2. German</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">1. Mostly unintelligible<break/>2. &#x02018;Articulation disorder&#x02019;; speech therapy ongoing</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">1. Impaired expressive &#x00026; receptive<break/>2. NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">1. Borderline IQ<break/>2. Average IQ at age 29y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">1. NR<break/>2. Working as industrial mechanic.</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1217T&#x0003e;C<break/>(1292T&#x0003e;C)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met406Thr&#x000a0;<sup>5</sup><break/>(Met431Thr)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2F<break/>2M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Turkish</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Polymicrogyria</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1658G&#x0003e;A<break/>(1733G&#x0003e;A)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg553His&#x000a0;<sup>6</sup><break/>(Arg578His)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">3 gen^</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">English</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Orofacial <break/>dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Borderline IQ</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1607G&#x0003e;C<break/>(1682G&#x0003e;C)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg536Pro<break/>(Arg561Pro&#x000a0;<sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1. 10y10m<break/>2. NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1F<break/>1M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">1. Impaired expressive &#x00026; receptive<break/>2. NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">1. Borderline IQ<break/>2. NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Friendly, some autisitic features (no formal diagnosis), mildly hypotonic.<break/>2. NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1614delT<break/>(1689delT)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe538Leufs<break/>(Phe563Leufs&#x000a0;<sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">19y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Poor pronunciation, no fluent speech at 15y; stilted intonation, stuttering and reluctance to speak at 19y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Poor expressive language at 15y<break/>Better receptive language w/appropriate responses to questions at 15y<break/>Able to read at write</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">ASD diagnosis at 15y; mainstream school with support; good at maths &#x00026; computers; morphology: small simply folded ears, prominent nose and chin with large protruding tongue, myopia</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1690C&#x0003e;T<break/>(1765C&#x0003e;T)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg564Ter<break/>(Arg589Ter&#x000a0;<sup>3</sup>)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">9y11m</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Severely impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">ASD diagnosis at 9y11m, mainstream school with learning support; fine motor deficits; unusual coughing sounds like choking as young child; normal hearing, left exotropia.</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1789A&#x0003e;C<break/>(1864A&#x0003e;C)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn597His&#x000a0;<sup>7</sup><break/>(Asn622His)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">7-9y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NAD</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Deletion exons 12-17&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2 (Monozygotic twins)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">11y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">&#x02018;Slurred articulation&#x02019;</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Speak in short sentences; reading &#x00026; writing impaired</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">FSIQ 1. 78; 2. 79<break/>Verbal comp: 77; 67<break/>Perceptual reasoning: 86; 88<break/>Working memory: 82; 88<break/>Processing speed: 88; 103</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Friendly and shy; normal EEG, morphology: epicanthic folds, mildly upslanting palpebral fissures, prominent incisors, sandal gaps.</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" colspan="11" align="left" scope="col" rowspan="1">
                  <bold><italic toggle="yes">FOXP2</italic> disruption by translocation</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">t(3;7)(q23;q31.2)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Translocation&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">t(5;7)(q22;q31.2)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Translocation&#x000a0;<sup>6,</sup>&#x000a0;<sup>9</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">5y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Verbal dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Severe <break/>orofacial <break/>dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Normal<break/>nonverbal<break/>skills</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">t(7;13)(q31.1;q13.2)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Translocation&#x000a0;<sup>10,</sup>&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">18-52y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">American</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS;<break/>spastic dysarthria</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">No orofacial <break/>apraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Low average</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" colspan="11" align="left" scope="col" rowspan="1">
                  <bold><italic toggle="yes">FOXP2</italic> and additional gene deletions</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31<break/>(2 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Upstream<break/>deletion&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Verbal dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NAD</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Dyslexia</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.31<break/>(8.3 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">3-28y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Estonian</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor<break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Poor <break/>vocabulary</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Moderate<break/>developmental<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Autistic features, eye disorder</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.2<break/>(6.5 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">6y/NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Estonian</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NAD</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Poor <break/>vocabulary</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Moderate ID</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Aggressive</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.3<break/>(14.8 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>14</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">10y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Italian</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Borderline IQ</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Fine praxis &#x00026;<break/>balance problems</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.2<break/>(1.57 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>15</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">4-24y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M/F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">American</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS,<break/>dysarthria</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Gagging &#x00026;<break/>drooling</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Severely <break/>impaired</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Low average /<break/>borderline IQ</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Fine &#x00026; gross motor planning difficulty,<break/>PDD-NOS</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.2<break/>(9.1 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>16</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">7y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">M</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Drooling, <break/>low oral <break/>motor tone</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Severely <break/>impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Moderate ID</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.3<break/>(16 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>17</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">5y</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Italian</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Verbal dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Severely <break/>impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Below average</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.3<break/>(11 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">ASD</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q31.3<break/>(15 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q33<break/>(30 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Severe dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Language<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.1-q33<break/>(30 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Severe dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Language<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.2-q32<break/>(13 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.2-q32<break/>(14 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Severe dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Language<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.2-q32<break/>(15 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31.2-q32<break/>(26 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Severe dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Language<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">ASD</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q22-q31.3<break/>(15 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>difficulties</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q22-q31.33<break/>(22 Mb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Severe dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Language<break/>delay</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" colspan="11" align="left" scope="col" rowspan="1">
                  <bold>Other / Complex variants</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">7q31<break/>(28 kb)</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pericentromeric inversion&#x000a0;<sup>18,</sup>&#x000a0;<sup>19</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Substitution, omission, mistiming of single articulations in a sequence</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Specific <break/>language impairment</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">Normal-low<break/>range</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">Impulsive behavior, sleep disturbance, obsessive compulsive symptoms, auditory hallucinations (all ceased following medication)</td>
              </tr>
              <tr>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">UPD7</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Uniparental<break/>disomy&#x000a0;<sup>8</sup></td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">7</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">CAS</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Oromotor <break/>dyspraxia</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Impaired expressive &#x00026; receptive</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                <td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver syndrome</related-object>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>NR = not reported</p>
            </fn>
            <fn>
              <p>Mo = mother</p>
            </fn>
            <fn>
              <p>MZ = monozygotic</p>
            </fn>
            <fn>
              <p>Gen = generation, mutation across three generations of the family</p>
            </fn>
            <fn>
              <p>PDD-NOS = pervasive developmental disorder, not otherwise specified</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.1">
              <label>1. </label>
              <p>Reference sequences for two alternative isoforms: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_014491.3">NM_014491.3</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_055306.1">NP_055306.1</ext-link> (Isoform I) &#x00026; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898">NM_148898</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_683696">NP_683696</ext-link> (Isoform II)</p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al [2005]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.turner.2013.2321">Turner et al [2013]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.5">
              <label>5. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.roll.2010.4848">Roll et al [2010]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.laffin.2012.928">Laffin et al [2012]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.8">
              <label>8. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.9">
              <label>9. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lai.2000.357">Lai et al [2000]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.10">
              <label>10. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al [2006]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.11">
              <label>11. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al [2009]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.12">
              <label>12. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.adegbola.2015.6848">Adegbola et al [2015]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.13">
              <label>13. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zilina.2012.254">Zilina et al [2012]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.14">
              <label>14. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.rice.2012.174">Rice et al [2012]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.15">
              <label>15. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.palka.2012.e183">Palka et al [2012]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.16">
              <label>16. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.lennon.2007.791">Lennon et al [2007]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.17">
              <label>17. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al [2006]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.18">
              <label>18. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.becker.2015.69">Becker et al [2015]</xref>
              </p>
            </fn>
            <fn id="foxp2-sl-dis.TF.3.19">
              <label>19. </label>
              <p>
                <xref ref-type="bibr" rid="foxp2-sl-dis.REF.moralli.2015.36">Moralli et al [2015]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The full-length FOXP2 protein assayed at the cellular level consists of 715 amino acid residues. The protein, Forkhead box protein P2, is a transcription factor with zinc finger (residues 346 to 371) and DNA binding (residues 504 to 594) functional domains (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.uniprot.org">UniProt</ext-link>). Forkhead box proteins are transcription factors that likely regulate hundreds of downstream target genes, some of which will be critical for development of speech and language.</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic missense variants, including those that disrupt the DNA binding domain (e.g., p.Arg553His [<xref ref-type="bibr" rid="foxp2-sl-dis.REF.vernes.2006.3154">Vernes et al 2006</xref>]), produce abnormal gene products that cannot bind DNA targets properly, as shown by functional studies of some variants.</p>
        <p>Other pathogenic missense variants may be associated with dominant-negative effects, which to date have not been demonstrated in published reports.</p>
        <p>Partial reduction in FOXP2 protein due to large copy number and complex variants (including deletions, translocations, and inversions) affecting one allele also leads to the clinical features of <italic toggle="yes">FOXP2-</italic>related disorders (<xref ref-type="table" rid="foxp2-sl-dis.T.foxp2_pathogenic_variants">Table 3</xref>).</p>
      </sec>
      <sec id="foxp2-sl-dis.References">
        <title>References</title>
        <sec id="foxp2-sl-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="foxp2-sl-dis.Literature_Cited.reflist0">
            <ref id="foxp2-sl-dis.REF.adegbola.2015.6848">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adegbola</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradshaw</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hafler</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimelbrant</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chess</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Monoallelic expression of the human FOXP2 speech gene.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2015</year>
                <volume>112</volume>
                <fpage>6848</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">25422445</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.alcock.2000.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alcock</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passingham</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Oral dyspraxia in inherited speech and language impairment and acquired dysphasia.</article-title>
                <source>Brain Lang.</source>
                <year>2000</year>
                <volume>75</volume>
                <fpage>17</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11023636</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF3">
              <mixed-citation publication-type="web">American Speech-Language-Hearing Association. Childhood apraxia of speech [Position Statement]. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.asha.org/policy/PS2007-00277/">online</ext-link>. 2007. Accessed 3-22-17</mixed-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.becker.2015.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devanna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernes</surname>
                    <given-names>SC</given-names>
                  </name>
                </person-group>
                <article-title>A chromosomal rearrangement in a child with severe speech and language disorder separates FOXP2 from a functional enhancer.</article-title>
                <source>Mol Cytogenet.</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>69</fpage>
                <pub-id pub-id-type="pmid">26300977</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.clark.2000.2160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <article-title>Worster-Drought syndrome, a mild tetraplegic perisylvian cerebral palsy. Review of 47 cases.</article-title>
                <source>Brain.</source>
                <year>2000</year>
                <volume>123</volume>
                <fpage>2160</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11004132</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.dodd.2003.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dodd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hua</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosbie</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Phonological development: a normative study of British English-speaking children.</article-title>
                <source>Clin Linguist Phon.</source>
                <year>2003</year>
                <volume>17</volume>
                <fpage>617</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">14977026</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.fedorenko.2016.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fedorenko</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardinaux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tager-Flusberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanwisher</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2016</year>
                <volume>24</volume>
                <fpage>310</fpage>
                <pub-id pub-id-type="pmid">26763793</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.fee.1995.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fee</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <article-title>The phonological system of a specifically language-impaired population.</article-title>
                <source>Clin Linguist Phon.</source>
                <year>1995</year>
                <volume>9</volume>
                <fpage>189</fpage>
                <lpage>209</lpage>
                <pub-id pub-id-type="pmid">21749311</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.feuk.2006.965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feuk</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalervo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipsanen-Nyman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skaug</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakabayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finucane</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartung</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerem</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowaczyk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivlin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szatmari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeesman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardy</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kere</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannula-Jouppi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2006</year>
                <volume>79</volume>
                <fpage>965</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17033973</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.fisher.1998.168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Localisation of a gene implicated in a severe speech and language disorder.</article-title>
                <source>Nat Genet.</source>
                <year>1998</year>
                <volume>18</volume>
                <fpage>168</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9462748</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.flipsen.2006.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flipsen</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Measuring the intelligibility of conversational speech in children.</article-title>
                <source>Clin Linguist Phon.</source>
                <year>2006</year>
                <volume>20</volume>
                <fpage>303</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16644588</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.gauthier.2003.172">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gauthier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joober</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mottron</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Kimpe</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <article-title>Mutation screening of FOXP2 in individuals diagnosed with autistic disorder.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>118A</volume>
                <fpage>172</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12655497</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.han.2014.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>TU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domingues</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moretti-Ferreira</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paris</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sainz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drayna</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>A study of the role of the FOXP2 and CNTNAP2 genes in persistent developmental stuttering.</article-title>
                <source>Neurobiol Dis.</source>
                <year>2014</year>
                <volume>69</volume>
                <fpage>23</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24807205</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.laffin.2012.928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laffin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strand</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakielski</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization.</article-title>
                <source>Genet Med.</source>
                <year>2012</year>
                <volume>14</volume>
                <fpage>928</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">22766611</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.lai.2000.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeremiah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Povey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamison</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2000</year>
                <volume>67</volume>
                <fpage>357</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">10880297</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.lai.2001.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder.</article-title>
                <source>Nature.</source>
                <year>2001</year>
                <volume>413</volume>
                <fpage>519</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11586359</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.law.2003.cd004110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nye</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Speech and language therapy interventions for children with primary speech and language delay or disorder.</article-title>
                <source>Cochrane Database Syst Rev.</source>
                <year>2003</year>
                <issue>3</issue>
                <fpage>CD004110</fpage>
                <pub-id pub-id-type="pmid">12918003</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.lennon.2007.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lennon</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peiffer</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunderson</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacino</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>791</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17330859</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.li_geois.2016.35192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li&#x000e9;geois</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonthrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connelly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <article-title>Early neuroimaging markers of FOXP2 intragenic deletion.</article-title>
                <source>Sci Rep.</source>
                <year>2016</year>
                <volume>6</volume>
                <fpage>35192</fpage>
                <pub-id pub-id-type="pmid">27734906</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.macdermot.2005.1074">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacDermot</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonora</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykes</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernes</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenzie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2005</year>
                <volume>76</volume>
                <fpage>1074</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15877281</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.moralli.2015.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moralli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nudel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volpi</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben&#x000ed;tez-Burraco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Bellido</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Language impairment in a case of a complex chromosomal rearrangement with a breakpoint downstream of FOXP2.</article-title>
                <source>Mol Cytogenet.</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>36</fpage>
                <pub-id pub-id-type="pmid">26060509</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.morgan.2010">
              <mixed-citation publication-type="book">Morgan AT, Li&#x000e9;geois F, Vargha-Khadem F. Motor speech outcome as a function of the site of brain pathology: A developmental perspective. Chap 6. In: Maassen B, van Lieshout P, eds. <italic toggle="yes">Speech Motor Control: New Developments in Basic and Applied Research.</italic> Oxford, UK: Oxford University Press; 2010:95-115.</mixed-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.morgan.2008.cd006278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>Intervention for childhood apraxia of speech.</article-title>
                <source>Cochrane Database Syst Rev.</source>
                <year>2008</year>
                <issue>3</issue>
                <fpage>CD006278</fpage>
                <pub-id pub-id-type="pmid">18646142</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.murray.2015">
              <mixed-citation publication-type="book">Murray E, McCabe P, Ballard KJ. A randomized controlled trial for children with childhood apraxia of speech comparing Rapid Syllable Transition treatment and the Nuffield Dyspraxia Programme -Third edition. J Speech Lang Hear Res. 2015; 58:669-86.</mixed-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.murray.2014.486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <article-title>A systematic review of treatment outcomes for children with childhood apraxia of speech.</article-title>
                <source>Am J Speech Lang Pathol.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>486</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">24686844</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.newbury.2002.1318">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newbury</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonora</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamb</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baird</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jannoun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slonims</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stott</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merricks</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolton</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>FOXP2 is not a major susceptibility gene for autism or specific language impairment.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2002</year>
                <volume>70</volume>
                <fpage>1318</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">11894222</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.palka.2012.e183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palka</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alfonsi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerbo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guanciali Franchi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fantasia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morizio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuppia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calabrese</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiarelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palka</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Mosaic 7q31 deletion involving FOXP2 gene associated with language impairment.</article-title>
                <source>Pediatrics.</source>
                <year>2012</year>
                <volume>129</volume>
                <fpage>e183</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22144704</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.pennington.2009.cd006937">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pennington</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Speech therapy for children with dysarthria acquired before three years of age.</article-title>
                <source>Cochrane Database Syst Rev.</source>
                <year>2009</year>
                <issue>4</issue>
                <fpage>CD006937</fpage>
                <pub-id pub-id-type="pmid">19821391</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.potter.2013.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nievergelt</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Motor and speech disorders in classic galactosemia.</article-title>
                <source>JIMD Rep.</source>
                <year>2013</year>
                <volume>11</volume>
                <fpage>31</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">23546812</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.rice.2012.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakielski</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laffin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyama-Kurtycz</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartley</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprague</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heintzelman</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>Phenotype of FOXP2 haploinsufficiency in a mother and son.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>174</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">22106036</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.reuter.2017.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reuter</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moog</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stampfer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steindl</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaser</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joset</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Study</surname>
                    <given-names>DDD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krumbiegel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulte-Mattler</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck-W&#x000f6;dl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zweier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.</article-title>
                <source>J Med Genet.</source>
                <year>2017</year>
                <volume>54</volume>
                <fpage>64</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">27572252</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.roll.2010.4848">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roll</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernes</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cillario</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsole-Lenfant</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massacrier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalife</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>4848</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">20858596</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF33">
              <mixed-citation publication-type="web">Royal College of Speech and Language Therapists. Policy statement on developmental verbal dyspraxia. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ndp3.org/documents/rcslt2011dvdPolicyStatement.pdf">online</ext-link>. 2011. Accessed 3-22-17</mixed-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.shriberg.1997.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aram</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwiatkowski</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Developmental apraxia of speech: I. Descriptive and theoretical perspectives.</article-title>
                <source>J Speech Lang Hear Res.</source>
                <year>1997</year>
                <volume>40</volume>
                <fpage>273</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">9130199</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.shriberg.2006.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomblin</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duffy</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odell</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2.</article-title>
                <source>J Speech Lang Hear Res.</source>
                <year>2006</year>
                <volume>49</volume>
                <fpage>500</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">16787893</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.shriberg.2011.487">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strand</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.</article-title>
                <source>J Speech Lang Hear Res.</source>
                <year>2011</year>
                <volume>54</volume>
                <fpage>487</fpage>
                <lpage>519</lpage>
                <pub-id pub-id-type="pmid">20966389</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.snowling.2012.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Snowling</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulme</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Interventions for children's language and literacy difficulties.</article-title>
                <source>Int J Lang Commun Disord.</source>
                <year>2012</year>
                <volume>47</volume>
                <fpage>27</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">22268899</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.tomblin.2009.1157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomblin</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shriberg</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjork</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Language features in a mother and daughter of a chromosome 7;13 translocation involving FOXP2.</article-title>
                <source>J Speech Lang Hear Res.</source>
                <year>2009</year>
                <volume>52</volume>
                <fpage>1157</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">19797137</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.turner.2013.2321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Block</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <article-title>Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>2321</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23918746</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.varghakhadem.2005.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadian</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copp</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishkin</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>FOXP2 and the neuroanatomy of speech and language.</article-title>
                <source>Nat Rev Neurosci.</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>131</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15685218</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.varghakhadem.1995.930">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alcock</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passingham</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Praxic and nonverbal cognitive deficits in a large family with a genetically transmitted speech and language disorder.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1995</year>
                <volume>92</volume>
                <fpage>930</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">7846081</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.varghakhadem.1998.12695">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashburner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alcock</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connelly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frackowiak</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friston</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishkin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadian</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passingham</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Neural basis of an inherited speech and language disorder.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1998</year>
                <volume>95</volume>
                <fpage>12695</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">9770548</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.velleman.2011.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Velleman</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mervis</surname>
                    <given-names>CB</given-names>
                  </name>
                </person-group>
                <article-title>Children with 7q11.23 Duplication Syndrome: Speech, Language, Cognitive, and Behavioral Characteristics and their Implications for Intervention.</article-title>
                <source>Perspect Lang Learn Educ.</source>
                <year>2011</year>
                <volume>18</volume>
                <fpage>108</fpage>
                <lpage>116</lpage>
                <pub-id pub-id-type="pmid">22754604</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.vernes.2006.3154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vernes</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicod</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elahi</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coventry</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenny</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Functional genetic analysis of mutations implicated in a human speech and language disorder.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>3154</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">16984964</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.watkins.2002.452">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dronkers</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargha-Khadem</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Behavioural analysis of an inherited speech and language disorder: comparison with acquired aphasia.</article-title>
                <source>Brain.</source>
                <year>2002</year>
                <volume>125</volume>
                <fpage>452</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">11872604</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.white.2010.821">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Da Costa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlston</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteford</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>The phenotype of Floating-Harbor syndrome in 10 patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>821</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20358590</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.zeesman.2006.509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeesman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowaczyk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teshima</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardy</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brian</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feuk</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                </person-group>
                <article-title>Speech and language impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>509</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16470794</pub-id>
              </element-citation>
            </ref>
            <ref id="foxp2-sl-dis.REF.zilina.2012.254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zilina</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimand</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zjablovskaja</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;nnik</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;nnamaa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puusepp-Benazzouz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ounap</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Maternally and paternally inherited deletion of 7q31 involving the FOXP2 gene in two families.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>254</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22105961</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="foxp2-sl-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="foxp2-sl-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>2 February 2017 (am) Revision: based on <xref ref-type="bibr" rid="foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</xref></p>
            </list-item>
            <list-item>
              <p>23 June 2016 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>4 August 2015 (am, msh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
